Of note, there were 36 of 72 (50%) tumors with ARID1A gene mutation showed tumor stage IV (Fig. 2B) and 52 of 79 (66%) cases with ARID1A mutations presented with T3/T4. Here, ARID1A is linked to neoplasm.